MORELLI, MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 6.326
AS - Asia 3.230
EU - Europa 2.183
SA - Sud America 500
Continente sconosciuto - Info sul continente non disponibili 128
AF - Africa 50
OC - Oceania 23
Totale 12.440
Nazione #
US - Stati Uniti d'America 6.056
SG - Singapore 1.452
IT - Italia 1.100
CN - Cina 918
BR - Brasile 379
IN - India 304
DE - Germania 296
VN - Vietnam 278
SE - Svezia 197
CA - Canada 185
GB - Regno Unito 161
FI - Finlandia 115
NL - Olanda 67
HK - Hong Kong 57
UA - Ucraina 50
AR - Argentina 49
MX - Messico 45
BD - Bangladesh 37
ES - Italia 37
ID - Indonesia 26
FR - Francia 25
RO - Romania 24
PL - Polonia 23
AU - Australia 22
JP - Giappone 22
PT - Portogallo 18
IQ - Iraq 17
TR - Turchia 17
ZA - Sudafrica 17
EC - Ecuador 16
CL - Cile 15
RU - Federazione Russa 14
SA - Arabia Saudita 14
PK - Pakistan 12
PY - Paraguay 12
CR - Costa Rica 10
CZ - Repubblica Ceca 10
IL - Israele 10
CO - Colombia 8
IE - Irlanda 8
IR - Iran 8
PE - Perù 8
MY - Malesia 7
AT - Austria 6
JM - Giamaica 6
KR - Corea 6
LT - Lituania 6
MA - Marocco 6
UY - Uruguay 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
JO - Giordania 5
KZ - Kazakistan 5
TN - Tunisia 5
UZ - Uzbekistan 5
AL - Albania 4
BE - Belgio 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
EU - Europa 4
GT - Guatemala 4
HN - Honduras 4
OM - Oman 4
TW - Taiwan 4
CH - Svizzera 3
EG - Egitto 3
GR - Grecia 3
KE - Kenya 3
LB - Libano 3
NG - Nigeria 3
RS - Serbia 3
TT - Trinidad e Tobago 3
BN - Brunei Darussalam 2
MK - Macedonia 2
PH - Filippine 2
SC - Seychelles 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
VC - Saint Vincent e Grenadine 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
HR - Croazia 1
KG - Kirghizistan 1
KY - Cayman, isole 1
LV - Lettonia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
SI - Slovenia 1
Totale 12.316
Città #
San Jose 1.064
Chandler 616
Ashburn 572
Dallas 408
Singapore 404
Santa Clara 292
Milan 242
Council Bluffs 241
Munich 224
Bengaluru 222
Hefei 218
Princeton 193
Lawrence 182
Chicago 130
Beijing 123
London 116
Ottawa 116
Wilmington 113
Ho Chi Minh City 106
Helsinki 68
New York 67
Hanoi 62
Des Moines 61
Rome 59
Catanzaro 53
Los Angeles 51
Hong Kong 49
Phoenix 46
Boardman 44
Guangzhou 44
Shanghai 43
Turku 43
Naples 39
Casalnuovo Di Napoli 35
São Paulo 34
Florence 25
Boston 23
Brooklyn 22
Denver 20
Toronto 19
Shenzhen 18
Atlanta 17
Boydton 17
Chennai 17
Montreal 17
Tokyo 17
Buffalo 16
Timisoara 16
Bari 15
Columbus 15
Rio de Janeiro 15
Warsaw 15
Haiphong 14
Norwalk 14
Orem 14
Hanover 13
Redwood City 13
Mexico City 12
Quattro Castella 12
The Dalles 12
Charlotte 11
Jiaxing 11
San Francisco 11
Jakarta 10
Montalto Uffugo 10
Seattle 10
Sydney 10
Altavilla Milicia 9
Belo Horizonte 9
Curitiba 9
Da Nang 9
Lamezia Terme 9
Manchester 9
Redmond 9
Santiago 9
Augusta 8
Hải Dương 8
Johannesburg 8
Madrid 8
Messina 8
Miami 8
Negrar 8
Pune 8
Washington 8
Amsterdam 7
Ankara 7
Baghdad 7
Bologna 7
Braga 7
Campinas 7
Cosenza 7
Frankfurt am Main 7
Guayaquil 7
Jeddah 7
Olomouc 7
Porto Alegre 7
Queens 7
Wuhan 7
Asunción 6
Aversa 6
Totale 7.115
Nome #
Magnetic Resonance Parkinsonism Index for evaluating disease progression rate in progressive supranuclear palsy: A longitudinal 2-year study 646
A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease. 186
null 175
Essential tremor and cognitive functioning: A clinical and imaging study 122
A new SLC20A2 mutation identified in southern Italy family with primary familial brain calcification. 102
Striatal dopamine transporter imaging and rest tremor pattern in early-stage tremulous patients: Implications for clinical practice 98
Hepatic Encephalopathy by Manganese Deposition: A Case Report and a Review of Literature 95
Neuropsychological heterogeneity in patients with primary familial brain calcification due to a novel mutation in SLC20A2 94
Analysis of the LRP10 gene in patients with Parkinson’s disease and dementia with Lewy bodies from Southern Italy 92
Incidental evidence of hypointensity in brain grey nuclei on routine MR imaging: when to suspect a neurodegenerative disorder? 89
Myocardial I-123-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD 87
Apomorphine-induced reorganization of striato-frontal connectivity in patients with tremor-dominant Parkinson's disease 86
Mutation analysis of the ATP13A2 gene in patients with PD and MSA from Italy 81
Clinical and imaging features of essential tremor-Parkinson disease (ET-PD) syndrome 79
A SLC20A2 mutation identified in an asymptomatic patient with brain calcification 77
Different hippocampal subfields involvement in AD and PDD: a multimodal 3T MRI study 76
Abnormal prefrontal gray matter in Parkinson’s disease patients with levodopa-induced dyskinesia: a combined voxel-based morphometry and cortical thickness study 76
In vivo evidence for decreased scyllo-inositol levels in the supplementary motor area of patients with Progressive Supranuclear Palsy: A proton MR spectroscopy study 76
Alterations of putaminal shape in de novo Parkinson’s disease 74
Cerebellar involvement in essential tremor with and without resting tremor: A Diffusion Tensor Imaging study 72
The embodiment of language in tremor-dominant Parkinson's disease patients 71
HMGA1 deficiency: a pathogenic link between tau pathology and insulin resistance 71
Association study between four polymorphisms in the HFE, TF and TFR genes and Parkinson's disease in Southern Italy 70
Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias. 70
Memory impairment in AD and PDD: hippocampal subfileds involvement and category cued recall 70
Anti-GAD associated inflammatory myopathy presenting with dropped head syndrome 70
Cardiac MIBG scintigraphy in Primary Progressive Freezing Gait 69
An innovative multimodal approach for differentiating vascular parkinsonism and Parkinson’s disease 69
A case of spinocerebellar ataxia type 17 (SCA 17) 68
Hippocampal impairment in patients with Essential Tremor: Hippocampal changes in ET 68
ANXA1 mutation analysis in Italian patients with early onset PD 67
Aging does not induce caudate nuclei and thalami hypointensities in healthy subjects: a 3.0 Tesla MR imaging study 67
Alterations of putaminal shape in de novo Parkinsos's disease 66
Different neuropsychological profile in patients with primary familial brain calcification 66
Alternating pattern distinguishes resting tremor of Parkinson’s disease from rest tremor associated with essential tremor 66
Magnetic Resonance Imaging Biomarkers Distinguish Normal Pressure Hydrocephalus From Progressive Supranuclear Palsy 66
ANXA1 mutation analysis in Italian patients with early onset PD 65
Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort Study 65
Corpus callosum damage in PSP and unsteady PD patients: A multimodal MRI study 65
Microstructural changes of normal-appearing white matter in Vascular Parkinsonism 65
Thalamic neurometabolic alterations in tremulous Parkinson's disease: A preliminary proton MR spectroscopy study. 65
Diffusion tensor imaging study of cerebellum in essential tremor with and without resting tremor 64
A double mutation in progranulin gene in behavioral variant frontotemporal dementia. A case report 64
Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease 64
Dropped head syndrome in a patient with FTD-ALS caused by abnormal expansion of C9orf72 gene 63
Clinical, electrophysiological, and imaging study in essential tremor-Parkinson's disease syndrome 63
Magnetic Resonance Parkinsonism Index for evaluating disease progression rate in progressive supranuclear palsy: A longitudinal 2-year study 63
Analysis of the TMEM230 gene in patients with multiple system atrophy 62
Cardiac MIBG scintigraphy for differentiation of the primary progressive freezing gait from PD 62
Measurement of third ventricle width for differentiation of progressive supranuclear palsy from Parkinson’s disease and multiple system atrophy 61
Adult-onset leukodystrophy and dystonic tremor: a case report 61
Differentiating between common PSP phenotypes using structural MRI: a machine learning study 60
Refining initial diagnosis of Parkinson's disease after follow-up: A 4-year prospective clinical and magnetic resonance imaging study. 59
Alpha-synuclein promoter haplotypes and dementia in Parkinson’s disease 59
Blink reflex recovery cycle in patients with essential tremor associated with resting tremor. 59
Sequencing of the ubiquitin carboxy-terminal hydrolase L1 and alpha-synuclein genes fails to reveal any mutations in PD “multiplex” families 59
Neurovascular compression in trigeminal neuralgia: a high-resolution brain MRI study 59
Myocardial 123I-metaiodobenzylguanidine uptake in genetic Parkinson’s disease 59
Thalamic tremor as onset of vascular parkinsonism 59
Hippocampal impairment in patients with Essential Tremor: Hippocampal changes in ET 59
REM-Sleep Behavior Disorder in Patients With Essential Tremor: What Is Its Clinical Significance? 59
Magnetic Resonance Planimetry in the Differential Diagnosis between Parkinson’s Disease and Progressive Supranuclear Palsy 58
Hyper-religiosity and visual hallucinations in a patient with frontotemporal dementia carrying a double variant in GRN gene 57
DCTN1 mutation analysis in Italian patients with PSP, MSA, and DLB 57
Fronto-parietal overactivation in patients with essential tremor during Stroop task 57
A new CHCHD2 mutation identified in a southern Italy patient with multiple system atrophy 57
Acute levodopa and ropinirole tests in Parkinson’s disease 57
Age at onset of Parkinson's disease influences neurodegenerative processes underlying levodopa-induced dyskinesias 57
Neuropsychological assessment could distinguish among different clinical phenotypes of progressive supranuclear palsy: A Machine Learning approach 57
Corticospinal tract abnormalities and ventricular dilatation: A transdiagnostic comparative tractography study 57
Hereditary Spastic Paraplegia Associated with Ultra-Rare Variant Enrichment Encompassing the SYNE1, CAPN1 and PGAP1 Genes 56
Identification of one novel mutation in GRN gene associated with frontotemporal dementia 56
The placebo effect on resting tremor in Parkinson’s disease: an electrophysiological study 56
Blink reflex recovery cycle distinguishes essential tremor with resting tremor from de novo Parkinson's disease 56
Brain iron deposition in essential tremor: a quantitative 3T MRI study 55
Accuracy of MR Parkinsonism Index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease 55
A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study 54
Early brainstem involvement in myotonic dystrophy type-1 54
Tacrolimus-induced polyneuropathy after heart transplantation 54
Facial dystonia as depicted in art in the time of Leonardo da Vinci 54
CSF protein concentration and opening pressure in idiopathic intracranial hypertension without papilledema 53
Imaging counterpart of postural instability and vertical ocular dysfunction in patients with PSP: A multimodal MRI study. 53
Shape-analysis of subcortical nuclei in progressive supranuclear palsy 53
Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson disease? 52
A fully automated, atlas-based approach for superior cerebellar peduncle evaluation in progressive supranuclear palsy phenotypes 52
Intraventricular tumour presenting as progressive supranuclear palsy-like phenotype 52
Analysis of the TMEM230 gene in familial Parkinson's disease from south Italy 51
Video-oculographic biomarkers for evaluating vertical ocular dysfunction in progressive supranuclear palsy 51
Structural connectivity differences in motor network between tremor-dominant and nontremor Parkinson's disease. 51
Cough tremor as presenting symptom of intraventricular tumor 51
Was the subjects portrayed in “A Man” by Cornelis Anthonisz around 1530 really affected by progressive supranuclear palsy? 51
Head tremor associated with unilateral rest tremor: ET, PD or other? 51
Genetic analysis of GBA1 gene in a cohort of patients with Parkinson's disease 50
An magnetic resonance imaging T2*-weighted sequence at short echo time to detect putaminal hypointensity in Parkinsonisms 50
Opicapone-induced reversible myopathy in a patient with advanced Parkinson’s disease and familial hyperCKemia 50
Track density imaging: A reliable method to assess white matter changes in Progressive Supranuclear Palsy with predominant parkinsonism 50
Brain iron deposition in essential tremor: a quantitative 3-Tesla magnetic resonance imaging study. 49
Tremor pattern differentiates drug-induced resting tremor from Parkinson disease. 49
Dat-Scan 123I-Ioflupane study in early Parkinson’s disease and essential tremor 49
Gradient echo MRI sequences for putaminal hypointensity in multiple system atrophy: the best choice of time echo 49
Totale 7.201
Categoria #
all - tutte 111.001
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.001


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022498 0 0 0 110 108 6 11 119 44 25 68 7
2022/20231.805 371 26 38 187 197 208 9 146 323 120 134 46
2023/2024862 154 104 68 66 68 172 26 34 12 51 48 59
2024/20252.557 331 249 177 133 119 324 113 128 302 69 200 412
2025/20265.066 254 578 444 678 616 258 720 229 687 368 169 65
2026/20271.239 72 318 600 249 0 0 0 0 0 0 0 0
Totale 12.440